142 related articles for article (PubMed ID: 35092415)
1. CAV1 is a prognostic predictor for patients with idiopathic pulmonary fibrosis and lung cancer.
Yin D; Qiu J; Hu S; Cheng L; Li H; Cheng X; Wang S; Lu J
J Biosci; 2022; 47():. PubMed ID: 35092415
[TBL] [Abstract][Full Text] [Related]
2. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
3. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis.
Li J; Wang B; Li X; Zhu Y
Med Sci Monit; 2020 Jul; 26():e922680. PubMed ID: 32669531
[TBL] [Abstract][Full Text] [Related]
5. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.
Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
[TBL] [Abstract][Full Text] [Related]
6. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and Their Association with Lung Cancer by Bioinformatics Analysis.
Velázquez-Enríquez JM; Reyes-Avendaño I; Santos-Álvarez JC; Reyes-Jiménez E; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Adv Respir Med; 2023 Oct; 91(5):407-431. PubMed ID: 37887075
[TBL] [Abstract][Full Text] [Related]
9. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
10. Identification of diagnostic hub genes related to neutrophils and infiltrating immune cell alterations in idiopathic pulmonary fibrosis.
Lin Y; Lai X; Huang S; Pu L; Zeng Q; Wang Z; Huang W
Front Immunol; 2023; 14():1078055. PubMed ID: 37334348
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Zheng Q; Min S; Zhou Q
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
[TBL] [Abstract][Full Text] [Related]
12. Identification of Hub Genes as Biomarkers Correlated with the Proliferation and Prognosis in Lung Cancer: A Weighted Gene Co-Expression Network Analysis.
Xu X; Xu L; Huang H; Li J; Dong S; Jin L; Ma Z; Li L
Biomed Res Int; 2020; 2020():3416807. PubMed ID: 32596300
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis.
Li N; Qiu L; Zeng C; Fang Z; Chen S; Song X; Song H; Zhang G
Ann Transl Med; 2021 Sep; 9(18):1459. PubMed ID: 34734011
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
15. Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis.
Wu Z; Chen H; Ke S; Mo L; Qiu M; Zhu G; Zhu W; Liu L
Sci Rep; 2023 Oct; 13(1):16559. PubMed ID: 37783761
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis.
Yao Y; Li Z; Gao W
Front Genet; 2022; 13():855789. PubMed ID: 35480306
[No Abstract] [Full Text] [Related]
18. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
19. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
Chen Q; Xia S; Sui H; Shi X; Huang B; Wang T
PLoS One; 2022; 17(1):e0262737. PubMed ID: 35045126
[TBL] [Abstract][Full Text] [Related]
20. Prediction and analysis of genetic effect in idiopathic pulmonary fibrosis and gastroesophageal reflux disease.
Chen P; Xie L; Ma L; Zhao X; Chen Y; Ge Z
IET Syst Biol; 2023 Dec; 17(6):352-365. PubMed ID: 37907428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
